Quick Summary
Crizano 250 Capsule
Last updated on 29 Jun 2026 | 03:18 AM (IST)
₹8249
MRP: ₹10999
(You Save ₹2750)
30 CAPSULE(s) IN A BOTTLE
25% OFF
₹8249
MRP: ₹10,999.00
Inclusive of all taxes
25% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Crikzo 250mg Capsule
HETERO HEALTHCA...
₹ 193.33/capsule
29% cheaper
Crizokast Capsule
APRAZER HEALTHC...
₹ 208.33/capsule
24% cheaper
Crizenta Capsule
ADLEY FORMULATI...
₹ 250.00/capsule
9% cheaper
Criznib Capsule
MEDION BIOTECH ...
₹ 260.83/capsule
5% cheaper
Introduction
Crizano 250 Capsule contains the active substance Crizotinib. It is an antineoplastic drug that belongs to the class of tyrosine kinase inhibitors. This medicine is prescribed to treat patients with a type of lung cancer called Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) that is locally advanced or metastatic (spread outside the lungs or to other parts of the body). Do not take this capsule if you are allergic to Crizotinib or any other ingredients of this medicine. Before initiating the treatment, inform your physician if you have had kidney, stomach, heart, or liver problems.
Notify your doctor if you have reduced white blood cells, abnormal heart tracing after ECG, vision problems, or if you take other medications. Report your doctor immediately if you are planning to get pregnant or think you may be pregnant. Talk to your doctor about effective contraceptives. Use effective birth control during the treatment because oral contraception is ineffective with this medicine, and use it at least for 90 days even after completing the therapy with Crizano 250 Capsule. It is advised to get suggestions about fertility concerns from your doctor. This medication is not recommended for adolescents and children under 18 years of age. Use sunscreen or protective clothing to cover the skin and protect it against sunburn. Crizano 250 Capsule prices vary by seller and location. Crizalk substitutes include Xalkori, Alectinib, Ceritinib, Lorlatinib, and Brigatinib, which are also used for ALK-positive non-small cell lung cancer.
Uses
Crizano 250 Capsule tablet uses are:
Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC).
How Crizano 250 Capsule Works
Crizotinib is a tyrosine kinase inhibitor that works by blocking the activity of the anaplastic lymphoma kinase (ALK) protein. It specifically targets the abnormal protein and blocks its activity, slowing down or stopping the growth and spread of cancer cells.
Interaction of Crizano 250 Capsule with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, recent vaccinations, nutritional and vitamin supplements, and herbal products. Certain medications such as Erythromycin, Diltiazem, Verapamil, and other medications may interact with Crizano 250 Capsule and reduce its effectiveness by causing undesirable side effects.
Storage Conditions
Store at room temperature (15-30˚C) in the original container
Keep this medicine out of the sight and reach of children.
How to take Crizano 250 Capsule
Take the Crizano 250 Capsule capsules at about the same time each day. The recommended dose is one capsule of 250 mg taken orally twice daily. Swallow the capsules whole and do not crush, chew, dissolve, or open them. Your physician will choose the Crizalk dosage and administration frequency based on your medical condition, as these vary from person to person.
How to take Crizano 250 Capsule
Take the Crizano 250 Capsule capsules at about the same time each day. The recommended dose is one capsule of 250 mg taken orally twice daily. Swallow the capsules whole and do not crush, chew, dissolve, or open them. Your physician will choose the Crizalk dosage and administration frequency based on your medical condition, as these vary from person to person.
Safety advice
Pregnancy
Crizano 250 Capsule is unsafe to use during pregnancy. Hence, check with your physician before taking this medicine if you are pregnant or think you might be pregnant.
Breast Feeding
It is unsafe to breastfeed while taking Crizano 250 Capsule because it can cause toxicity to the baby. Consult your physician for more information.
Lungs
Inform your doctor immediately if you experience any symptoms such as lung inflammation, difficulty breathing, a cough with or without mucus, or fever while taking Crizano 250 Capsule.
Liver
Inform your physician about any underlying liver disorders before taking Crizano 250 Capsule, as this medication should be used with caution in patients with liver disease. Consult your physician before taking this medicine.
Alcohol
It is not known whether it is safe to consume alcohol with Crizano 250 Capsule. Please consult your doctor.
Driving
It is unsafe to drive while taking Crizano 250 Capsule because this medicine may cause dizziness and fatigue; avoid driving and operating machinery during this treatment.
Side Effects
Crizano 250 Capsule side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
Pain in the right side of the stomach
Partial or full loss of vision
Lowered WBC
Low heart rate.
Swelling of the lungs.
Breathlessness
Cough with or without mucus
Common
Sensitivity to sunlight.
Diarrhea
Fever
Constipation
Nausea
Increased liver enzymes
Decreased appetite, Tiredness (fatigue)
Dizziness
Neuropathy (weakness, tingling, or numbness in the nerve)
Dysgeusia ( taste disorder)
Hypophosphataemia (low levels of phosphate in the blood)
Expert Tips
Blood Health: Inform your doctor if you notice a reduced number of white blood cells (leucopenia) or red blood cells (anaemia), which may cause pale skin, weakness, or breathlessness.
Heart Monitoring: Your doctor may suggest an electrocardiogram to check your heart function and detect any slower heart rate.
Dosage: Take Crizano 250 Capsule every day exactly as prescribed by your doctor without missing doses.
Precautions: Limit sun exposure to avoid photosensitivity and inform your doctor if you experience stomach problems, ankle swelling, or other unusual symptoms.
FAQs
Q1.
Does Crizano 250 Capsule cure cancer?
Crizano 250 Capsule is not a cure for cancer, but it can help to slow down or stop the growth and spread of cancer cells, improving the overall survival and quality of life of patients with certain types of cancer.
Q2.
What should I do if I miss a dose of Crizano 250 Capsule?
If you miss a dose of Crizano 250 Capsule, you should take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
Q3.
What should I tell my doctor before taking Crizano 250 Capsule?
Before taking Crizano 250 Capsule, you should tell your doctor if you have liver or kidney problems, a history of heart disease, or are pregnant or planning to become pregnant.
Q4.
Why are there low levels of phosphate in the blood while taking Crizano 250 Capsule?
The exact mechanism by which Crizano 250 Capsule causes hypophosphatemia (low phosphate levels) is not fully understood, but it is thought to involve inhibition of enzymes involved in phosphate transport and metabolism.
Q5.
Can Crizano 250 Capsule be used in combination with other cancer medications?
Crizano 250 Capsule may be used in combination with the chemotherapy drugs Pemetrexed and Cisplatin in the first-line treatment of ALK-positive non-small cell lung cancer (NSCLC). It depends on the specific cancer diagnosis and treatment plan.
Fact Box
Molecule name: | Crizotinib |
Therapeutic class: | Antineoplastic drug |
Pharmacological class: | Tyrosine kinase inhibitors |
Indication: | Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) |
References
David Eric Gerber, ECOG-ACRIN Cancer Research Group, ClinicalTrials.gov IDNCT02201992 [Accessed on 30th Mar 2021],
https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2014-01507&r=1
Pfizer, Electronic Medicines Compendium (EMC), [Revised on Jun 2022], [Accessed on 19th April 2023], ANNEX I (medicines.org.uk)
Anton Wellstein, Giuseppe Giaccone, Michael B. Atkins, and Edward A. Sausville, Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules, Goodman & Gilman’s Pharmacological Basis of Therapeutics, 13th Edition, 2018, 1203-1236.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Vikas B S
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 29 Jun 2026 | 03:18 AM (IST)
Want to know more?
Read Our Editorial Policy